Edwards Lifesciences | EW - 贷款资金

股票价格

82.69

每天变化

1.47 1.81%

每月一次

3.26%

每年

9.99%

Q2 预测

82.35

金融业

USD

USD 13.7B

现金及等价物

USD 2.4B

USD 362.6M

USD 6.74B

USD 1.81B

USD 600M

USD 514.7M

USD 70.1M

15.8K

EPS每股收益

USD 0.78

股本和储备

USD 10.34B

USD 1.29B

债务利息支出

USD 35.9M

USD 56.3M

USD 600M

USD 48.06B

USD 380.7M

USD 1.13B

USD 514.7M

普通股股本

USD 580.7M

26.87

USD 348.4M

USD 1.65B

销售和管理费用

USD 522.2M

USD 1.13B

贸易债权人

USD 227.5M

应收帐款人

USD 912.1M

	贷款资金	更改		日
Abbott	USD 29.64B		19.74B	2026-03
Artivion	USD 217.81M		2.94M	2025-12
AtriCure	USD 61.86M		0	2025-12
Baxter International	USD 9.47B		726M	2025-12
Becton, Dickinson and Co.	USD 16.92B		705M	2025-12
Boston Scientific	USD 11.01B		19M	2025-12
Cooper Companies	USD 1.88B		578.5M	2025-12
Dexcom	USD 1.24B		53.6M	2025-12
Edwards Lifesciences	USD 600M		1.7M	2026-03
Globus Medical	USD 436K		9K	2025-12
ICU Medical	USD 1.27B		48.01M	2025-12
Inogen	USD 0		0	2022-06
Insulet	USD 930.8M		4.1M	2025-12
Integra LifeSciences	USD 1.86B		63.76M	2025-12
Intuitive Surgical	USD 0		0	2025-03
J&J	USD 37.53B		1.91B	2026-03
Masimo	USD 518M		41.1M	2025-12
Medtronic	USD 27.88B		255M	2025-12
Merit Medical Systems	USD 734.04M		1.12M	2025-12
Stryker	USD 14.86B		14M	2025-12
Tandem Diabetes Care	USD 310.04M		446K	2025-12
Teleflex	USD 2.54B		30.06M	2025-12
Zimmer Biomet Holdings	USD 6.3B		636.9M	2026-03